Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Advaxis initiates phase I study of ADXS-HER2 for HER2-expressing solid tumors

Sep. 30, 2015

CIRM grants USD 19.9 million to ImmunoCellular for the funding of ICT-107

Sep. 29, 2015

EMA CHMP grants accelerated assessment of Janssen's daratumumab for MM

Sep. 25, 2015

Genmab and Novartis granted priority review for ofatumumab sBLA

Sep. 21, 2015

Infinity Pharmaceuticals adds IPI-549 to its pipeline for the treatment of solid tumors

Sep. 21, 2015

EnGeneIC to begin U.S. phase I study of (EGFR)-EDV-dox

Sep. 18, 2015

Opdivo receives FDA breakthrough therapy designation for renal cell carcinoma

Sep. 17, 2015

Glenmark Pharmaceuticals' GBR-1302 to enter phase I trials

Sep. 16, 2015

FDA OOPD awards grant to support development of ADXS-HPV in throat cancer

Sep. 16, 2015

TC Biopharm granted CTA approval to treat cancer patients with ImmuniCell

Sep. 14, 2015

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.